相关实验视频

Updated: Jun 16, 2026

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

1,3,4-亚二醇衍生物的合成及其抗癌评估

Camelia Elena Stecoza¹, George Mihai Nitulescu¹, Constantin Draghici²

¹Faculty of Pharmacy, "Carol Davila" University of Medicine and Pharmacy, 6 Traian Vuia Street, 020956 Bucharest, Romania.

International journal of molecular sciences

|December 23, 2023

概括

新的亚二醇衍生物显示出作为抗癌剂的前景. 化合物2g有效地抑制了具有低毒性的LoVo和MCF-7系的癌细胞生长,这表明药物开发的潜力.

科学领域:

药用化学医学化学
药理学药理学是指药理学的学科.
药物发现药物发现药物发现

背景情况:

提亚醇衍生物被认为具有多种药理学作用.
提亚二醇化合物的抗癌性质具有显著的兴趣.
新型亚二醇衍生物需要合成和评估治疗潜力.

研究的目的:

为了合成新型的亚二醇衍生物.
用核磁共振 (NMR) 光谱学来表征合成的化合物.
评估这些衍生物的抗癌潜力和毒性.

主要方法:

提亚二醇衍生物的合成.
通过NMR进行化学表征.
在LoVo和MCF-7细胞系上进行的in silico和in vitro抗癌测定 (活力,增殖,细胞亡,细胞循环).
使用*Daphnia magna*进行毒性评估.

主要成果:

成功合成和NMR确认了亚二醇衍生物.
几种衍生物对LoVo和MCF-7细胞系表现出有前途的抗癌活性.
化合物2g显示出显著的抗增殖作用 (IC50:LoVo的2.44μM,MCF-7的23.29μM) 与最小的*达芬菌*毒性.

结论:

合成的亚二醇衍生物具有作为抗癌化合物的潜力.
化合物2g是癌症药物开发中进一步研究的有希望的候选物.
这项研究强调了在瘤学中滴亚二醇支架的治疗意义.

关键词:

这是一种2-氨基-1,3,4-提亚迪亚二醇.达芬尼亚大 (Daphnia magna) 是一个大.洛沃的细胞是LoVo的细胞.细胞中的MCF-7细胞.通过预测 PASS 预测细胞周期分析分析细胞周期分析诱导了阿波灭的发生.提亚二醇衍生物的提亚二醇衍生物.

更多相关视频

Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates

Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates

Published on: March 6, 2019

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Published on: November 10, 2013

相关概念视频

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...